High levels of women's satisfaction and compliance with transdermal contraception: results from a European multinational, 6-month study

References

• Graziottin A. A review of transdermal hormonal contraception. Focus on the ethinylestradiol/norelgestromin contraceptive patch. Treat Endocrinol 2006;5:359–365.
   PubMedGoogle Scholar
• Graziottin A. Safety, efficacy and patient acceptability of the combined estrogen and progestin transdermal contraceptive patch: a review. Patient Prefer Adherence 2008:2;357–367.
   PubMedGoogle Scholar
• Zieman M, Guillebaud J, Weisberg E, Shangold GA, Fisher AC, Creasy GW. Contraceptive efficacy and cycle control with the Ortho Evra/Evra transdermal system: the analysis of pooled data. Fertil Steril 2002;77:S13–S18.
   PubMed Web of Science ®Google Scholar
• Burkman RT. Transdermal hormonal contraception: benefits and risks. Am J Obstet Gynecol 2007;197:134.e1–134.e6.
   PubMed Web of Science ®Google Scholar
• Jick SS, Kaye JA, Russmann S, Jick H. Risk of nonfatal venous thromboembolism in women using a contraceptive transdermal patch and oral contraceptives containing norgestimate and 35 μg of ethyl estradiol. Contraception 2006;73:223–228.
   PubMed Web of Science ®Google Scholar
• Jick S, Kaye JA, Li L, Jick H. Further results on the risk of nonfatal venous thromboembolism in users of the contraceptive transdermal patch compared to users of oral contraceptives containing norgestimate and 35 μg of ethinyl estradiol. Contraception 2007;76:4–7.
   PubMed Web of Science ®Google Scholar
• Cole JA, Norman H, Doherty M, Walker AM. Venous thromboembolism, myocardial infarction, and stroke among transdermal contraceptive system users. Obstet Gynecol 2007;109 (2 Pt 1):339–346.
   PubMed Web of Science ®Google Scholar
• Jick SS, Hagberg KW, Hernandez RK, Kaye JA. Postmarketing study of ORTHO EVRA® and levonogestrel oral contraceptives containing hormonal contraceptives with 30 mcg of ethinyl estradiol in relation to nonfatal venous thromboembolism. Contraception 2010;81:16–21.
   PubMed Web of Science ®Google Scholar
• Dore DD, Norman H, Seeger JD. Eligibility criteria in venous thromboembolism, myocardial infarction, and stroke among transdermal contraceptive users. Letter to the editor of Obstet Gynecol 2009;114:175.
   Google Scholar
• Dore DD, Norman H, Loughlin J, Seeger JD. Extended case-control study results on thromboembolic outcomes among transdermal contraceptive users. Contraception 2010;81:408–413.
   PubMed Web of Science ®Google Scholar
• Wan GJ, Barnowski CE, Ambegaonkar BM, Bolge SC, McDonnell DD. Treatment satisfaction with a transdermal contraceptive patch or oral contraceptives. Contraception 2007;73:281–284.
   Google Scholar
• Archer DF, Bigrigg A, Smallwood GH, Shangold GA, Creasy GW, Fisher AC. Assessment of compliance with a weekly contraceptive patch (Ortho Evra™/Evra™) among North American Women. Fertil Steril 2002;77 (suppl 2):S27–S31.
   PubMed Web of Science ®Google Scholar
• Urdl W, Apter D, Alperstein A, Koll P, Schonian S, Bringer J, Fisher AC, Preik M. Contraceptive efficacy, compliance and beyond: factors related to satisfaction with once-weekly transdermal compared with oral contraception. Eur J Obstet Gynecol Reprod Biol 2005;121:202–210.
   PubMed Web of Science ®Google Scholar
• Lopez LM, Grimes DA, Gallo MF, Schulz KF. Skin patch and vaginal ring versus combined oral contraceptives for contraception (Review). The Cochrane Collaboration. Wiley: 2008.
   Google Scholar
• Audet MC, Moreau M, Koltun WD, Waldbaum AS, Shangold G, Fisher AC, Creasy GW. Evaluation of contraceptive efficacy and cycle control of a transdermal contraceptive patch vs. an oral contraceptive: a randomized controlled trial. JAMA 2001;285:2347–2354.
   PubMed Web of Science ®Google Scholar
• Archer DF, Cullins V, Creasy GW, Fisher AC. The impact of improved compliance with a weekly contraceptive transdermal system (Ortho Evra) on contraceptive efficacy. Contraception 2004;69:189–195.
   PubMed Web of Science ®Google Scholar
• Crosignani PG, Nappi C, Ronsini S, Bruni V, Marelli S, Sonnino D; and the EVRA Contrast Study Group. Satisfaction and compliance in hormonal contraception: the result of a Multicentre Clinical Study on Women's Experience with the ethinylestradiol/norelgestromin contraceptive patch in Italy. BMC Woman's Health 2009;9:18.
   Google Scholar
• Ware J Jr, Kosinski M, Keller SD. A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity. Med Care 1996;34:220–233.
   PubMed Web of Science ®Google Scholar
• Ware JE Jr, Kosinski M, Turner-Bowker DM, Gandek B. How to score Version 2 of the SF-12 Health Survey (with a supplement documenting version 1). Boston: QualityMetric Incorporated; 2004.
   Google Scholar
• Weisberg F, Bouchard C, Moreau M, Audet MC, Mawdsley S, Dattani D, Dinniwell J, Horbay GL. Preference for and satisfaction of Canadian women with the transdermal contraceptive patch versus previous contraceptive method: an open-label, multicentre study. J Obstet Gynaecol Can 2005;27:350–359.
   PubMedGoogle Scholar
• Creasy GW, Abrams LS, Fisher AC. Transdermal contraception. Semin Reprod Med 2001;19:373–380.
   PubMedGoogle Scholar
• Smallwood GH, Meador ML, Lenihan JP, Shangold GA, Fisher AC, Creasy GW. Efficacy and safety of a transdermal contraceptive system. Obstet Gynecol 2001;98:799–805.
   PubMed Web of Science ®Google Scholar
• Richter A, Anton SE, Koch P, Dennett SL. The impact of reducing dose frequency on health outcomes. Clin Ther 2003;25:2307–2335.
   PubMed Web of Science ®Google Scholar
• Gallo MF, Grimes DA, Schulz KF. Skin patch and vaginal ring versus combined oral contraceptives for contraception. Cochrane Database Syst Rev 2003;CD003552.
   Google Scholar